Clinically relevant plasma proteome for adiposity depots: evidence from systematic mendelian randomization and colocalization analyses
Abstract Background The accumulation of visceral and ectopic fat comprise a major cause of cardiometabolic diseases. However, novel drug targets for reducing unnecessary visceral and ectopic fat are still limited. Our study aims to provide a comprehensive investigation of the causal effects of the p...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2024-04-01
|
Series: | Cardiovascular Diabetology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12933-024-02222-1 |
_version_ | 1797209571393011712 |
---|---|
author | Min Cao Bin Cui |
author_facet | Min Cao Bin Cui |
author_sort | Min Cao |
collection | DOAJ |
description | Abstract Background The accumulation of visceral and ectopic fat comprise a major cause of cardiometabolic diseases. However, novel drug targets for reducing unnecessary visceral and ectopic fat are still limited. Our study aims to provide a comprehensive investigation of the causal effects of the plasma proteome on visceral and ectopic fat using Mendelian randomization (MR) approach. Methods We performed two-sample MR analyses based on five large genome-wide association study (GWAS) summary statistics of 2656 plasma proteins, to screen for causal associations of these proteins with traits of visceral and ectopic fat in over 30,000 participants of European ancestry, as well as to assess mediation effects by risk factors of outcomes. The colocalization analysis was conducted to examine whether the identified proteins and outcomes shared casual variants. Results Genetically predicted levels of 14 circulating proteins were associated with visceral and ectopic fat (P < 4.99 × 10− 5, at a Bonferroni-corrected threshold). Colocalization analysis prioritized ten protein targets that showed effect on outcomes, including FST, SIRT2, DNAJB9, IL6R, CTSA, RGMB, PNLIPRP1, FLT4, PPY and IL6ST. MR analyses revealed seven risk factors for visceral and ectopic fat (P < 0.0024). Furthermore, the associations of CTSA, DNAJB9 and IGFBP1 with primary outcomes were mediated by HDL-C and SHBG. Sensitivity analyses showed little evidence of pleiotropy. Conclusions Our study identified candidate proteins showing putative causal effects as potential therapeutic targets for visceral and ectopic fat accumulation and outlined causal pathways for further prevention of downstream cardiometabolic diseases. |
first_indexed | 2024-04-24T09:56:49Z |
format | Article |
id | doaj.art-89c0b064d7b74b4693a01e77219d4172 |
institution | Directory Open Access Journal |
issn | 1475-2840 |
language | English |
last_indexed | 2024-04-24T09:56:49Z |
publishDate | 2024-04-01 |
publisher | BMC |
record_format | Article |
series | Cardiovascular Diabetology |
spelling | doaj.art-89c0b064d7b74b4693a01e77219d41722024-04-14T11:07:08ZengBMCCardiovascular Diabetology1475-28402024-04-0123111110.1186/s12933-024-02222-1Clinically relevant plasma proteome for adiposity depots: evidence from systematic mendelian randomization and colocalization analysesMin Cao0Bin Cui1Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of MedicineDepartment of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of MedicineAbstract Background The accumulation of visceral and ectopic fat comprise a major cause of cardiometabolic diseases. However, novel drug targets for reducing unnecessary visceral and ectopic fat are still limited. Our study aims to provide a comprehensive investigation of the causal effects of the plasma proteome on visceral and ectopic fat using Mendelian randomization (MR) approach. Methods We performed two-sample MR analyses based on five large genome-wide association study (GWAS) summary statistics of 2656 plasma proteins, to screen for causal associations of these proteins with traits of visceral and ectopic fat in over 30,000 participants of European ancestry, as well as to assess mediation effects by risk factors of outcomes. The colocalization analysis was conducted to examine whether the identified proteins and outcomes shared casual variants. Results Genetically predicted levels of 14 circulating proteins were associated with visceral and ectopic fat (P < 4.99 × 10− 5, at a Bonferroni-corrected threshold). Colocalization analysis prioritized ten protein targets that showed effect on outcomes, including FST, SIRT2, DNAJB9, IL6R, CTSA, RGMB, PNLIPRP1, FLT4, PPY and IL6ST. MR analyses revealed seven risk factors for visceral and ectopic fat (P < 0.0024). Furthermore, the associations of CTSA, DNAJB9 and IGFBP1 with primary outcomes were mediated by HDL-C and SHBG. Sensitivity analyses showed little evidence of pleiotropy. Conclusions Our study identified candidate proteins showing putative causal effects as potential therapeutic targets for visceral and ectopic fat accumulation and outlined causal pathways for further prevention of downstream cardiometabolic diseases.https://doi.org/10.1186/s12933-024-02222-1Adiposity depotsPlasma proteomeMendelian randomizationColocalizationRisk factorsDrug targets |
spellingShingle | Min Cao Bin Cui Clinically relevant plasma proteome for adiposity depots: evidence from systematic mendelian randomization and colocalization analyses Cardiovascular Diabetology Adiposity depots Plasma proteome Mendelian randomization Colocalization Risk factors Drug targets |
title | Clinically relevant plasma proteome for adiposity depots: evidence from systematic mendelian randomization and colocalization analyses |
title_full | Clinically relevant plasma proteome for adiposity depots: evidence from systematic mendelian randomization and colocalization analyses |
title_fullStr | Clinically relevant plasma proteome for adiposity depots: evidence from systematic mendelian randomization and colocalization analyses |
title_full_unstemmed | Clinically relevant plasma proteome for adiposity depots: evidence from systematic mendelian randomization and colocalization analyses |
title_short | Clinically relevant plasma proteome for adiposity depots: evidence from systematic mendelian randomization and colocalization analyses |
title_sort | clinically relevant plasma proteome for adiposity depots evidence from systematic mendelian randomization and colocalization analyses |
topic | Adiposity depots Plasma proteome Mendelian randomization Colocalization Risk factors Drug targets |
url | https://doi.org/10.1186/s12933-024-02222-1 |
work_keys_str_mv | AT mincao clinicallyrelevantplasmaproteomeforadipositydepotsevidencefromsystematicmendelianrandomizationandcolocalizationanalyses AT bincui clinicallyrelevantplasmaproteomeforadipositydepotsevidencefromsystematicmendelianrandomizationandcolocalizationanalyses |